Atai Life Sciences N.V. (ATAI) — DEFA14A Filings

All DEFA14A filings from Atai Life Sciences N.V.. Browse 3 DEFA14A reports with AI-powered summaries and risk analysis.

DEFA14A Filings (3)

  • ATAI Life Sciences N.V. Proxy Statement Filed — Jul 2, 2025 Risk: low
    ATAI Life Sciences N.V. filed a Definitive Proxy Statement (DEFA14A) on July 2, 2025, related to soliciting materials under Rule 14a-12. The filing indicates no
  • ATAI Life Sciences N.V. Proxy Statement Filed — Jun 18, 2025 Risk: low
    ATAI Life Sciences N.V. filed a DEFA14A proxy statement on June 18, 2025, related to the 6th annual HC Wainwright Neuro perspectives Conference. The filing indi
  • ATAI Life Sciences N.V. Proxy Statement Filed — Jun 3, 2025 Risk: low
    ATAI Life Sciences N.V. filed a DEFA14A proxy statement on June 3, 2025, related to soliciting material under Rule 14a-12. The filing indicates no fee was requi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.